Maccon Keane

9.7k citations

72 papers · 3.4k indexed · h-index 27

Cancer Research top 2%
- Breast Cancer Treatment Studies 19
- NF-κB Signaling Pathways 7
Oncology top 2%
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 8
Immunology top 5%
Internal Medicine top 5%
Molecular Biology top 5%
- Cell death mechanisms and regulation 9
Pulmonary and Respiratory Medicine
- Advanced Breast Cancer Therapies 8
- Lung Cancer Treatments and Mutations 6
Pathology and Forensic Medicine
- Breast Lesions and Carcinomas 6

Co-authors: Seth A. Ettenberg Marion M. Nau Stan Lipkowitz E K Russell Stanley Lipkowitz Mauricio Cuello Devalingam Mahalingam Afshin Samali
Cited by: Cancer Research Oncology Immunology
Journals: Journal of Clinical Oncology (11 papers)Breast Cancer Research and Treatment (6 papers)Cancer Research (5 papers)
Partner nations: Ireland United States United Kingdom

In The Last Decade

Maccon Keane

71 papers receiving 3.4k citations

Peers

Countries citing papers authored by Maccon Keane

Since Specialization

Citations

This map shows the geographic impact of Maccon Keane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maccon Keane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maccon Keane more than expected).

Fields of papers citing papers by Maccon Keane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maccon Keane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maccon Keane. The network helps show where Maccon Keane may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maccon Keane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maccon Keane Line = papers co-authored together Maccon Keane links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland Current Oncology ·Phil Ormrod,F. Gosselck,Hao Liu,Fergus Keane,Denis Evoy,James Geraghty,Jane Rothwell,Damian McCartan,Megan Greally,Miriam O’Connor,Deirdre O’Mahony,Maccon Keane,Michael J. Kennedy,Séamus O’Reilly,Thomas Seyffarth,John Crown,Catherine M. Kelly,Ruth Prichard,Cecily Quinn,Janice M. Walshe	2024	1
2	Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland Breast Cancer Research and Treatment ·Phil Ormrod,F. Gosselck,Hao Liu,Ch. Nafz,Clement Owusu-Cole,Denis Evoy,James Geraghty,R S Prichard,Jane Rothwell,Damian McCartan,E. McDermott,Maccon Keane,Michael J. Kennedy,Séamus O’Reilly,Thomas Seyffarth,John Crown,Lillian M. Smyth,Catherine M. Kelly,Cecily Quinn,Janice M. Walshe	2021	6
3	Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study The Breast ·Matthew G. Davey,Vincenzo Salamone,Rhia Shah,Elizabeth A. Maher,Charles Inglin,Peter McAnena,Ray McLaughlin,Karl Sweeney,C. Elsden,Carmel Malone,W. Wyns,Osama Soliman,Nicola Miller,Maccon Keane,Aoïfe Lowery,Michael J. Kerin	2021	21
4	A Review of the Impact of Neoadjuvant Chemotherapy on Breast Surgery Practice and Outcomes Clinical Breast Cancer ·Susy Fanny,Aoïfe Lowery,Catherine Curran,Ray McLaughlin,Carmel Malone,Karl Sweeney,Maccon Keane,Michael J. Kerin	2019	22
5	Neoadjuvant chemoradiation and breast reconstruction: the potential for improved outcomes in the treatment of breast cancer Irish Journal of Medical Science (1971 -) ·渡辺洋子,Terri McVeigh,Joseph D. Martin,Maccon Keane,Aoïfe Lowery,Michael J. Kerin	2018	17
6	Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial Journal of Clinical Oncology ·Amir Sonnenblick,Dominique Agbor‐Tarh,Ian Bradbury,Serena Di Cosimo,Hatem A. Azim,Debora Fumagalli,Séverine Sarp,Antonio C. Wolff,Michael Andersson,Judith R. Kroep,Tanja Čufer,Sérgio D. Simon,Pamela Salman,Masakazu Toi,Lyndsay N. Harris,Julie R. Gralow,Maccon Keane,Alvaro Moreno‐Aspitia,Martine Piccart,Evandro de Azambuja	2017	106
7	Do oncology patients understand clinical trials? A nationwide study by Cancer Trials Ireland Annals of Oncology ·Catherine M. Kelly,Shishina Rn,John McCaffrey,Fachgruppe Chemieunterricht,Michelle L. Smith,Séamus O’Reilly,Conleth G. Murphy,Anne M. Horgan,J.M. Walshe,Ray McDermott,Dearbhaile M. O’Donnell,Patrick G. Morris,Maccon Keane,Michael J. Martin,Marília de Araújo Costa Rodrigues,Alina Mihai,John Armstrong,P. Dagnelie,Verena Murphy	2017	6
8	Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes Critical Reviews™ in Oncogenesis ·Elaine M. Walsh,Maccon Keane,David A. Wink,Grace Callagy,Sharon A. Glynn	2016	44
9	Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial The Lancet Oncology ·Robert E. Coleman,David Cameron,David Dodwell,Richard H. Bell,Caroline Wilson,Emma Rathbone,Maccon Keane,Miguel Gil‐Gil,Roger Burkinshaw,Robert Grieve,Peter Barrett‐Lee,Diana Ritchie,Pogozheva EIu,Samantha Hinsley,Helen Marshall	2014	202
10	An unusual presentation of MEN2A BMJ Case Reports ·Ruth Casey,M. J. Bell,Maccon Keane,Andrew Smyth	2013	2
11	Fertility preservation in young females with non-gynaecologic malignancy: an emerging speciality Irish Journal of Medical Science (1971 -) ·C. Smyth,Mirjam Wasner,Lucy Higgins,Doris HOCHBAUM,Michael J. O’Leary,Maccon Keane,Jinglin Zhou,Kevin Barry	2013	2
12	Assessing the Impact of Neoadjuvant Chemotherapy on the Management of the Breast and Axilla in Breast Cancer Clinical Breast Cancer ·Terri McVeigh,Dhafir Al-Azawi,周聪,Carmel Malone,Karl Sweeney,Kevin Barry,H. Henning,Maccon Keane,Michael J. Kerin	2013	15
13	Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells British Journal of Cancer ·Devalingam Mahalingam,Alessandro Natoni,Maccon Keane,Afshin Samali,Éva Szegezdi	2010	37
14	The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer British Journal of Cancer ·(unknown),Robert E. Coleman,Matthew Winter,David Cameron,R. Bell,David Dodwell,Maccon Keane,(unknown),Diana Ritchie,José Luís Passos‐Coelho,Duncan Wheatley,Roger Burkinshaw,Helen Marshall,H. Thorpe	2010	168
15	Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines British Journal of Cancer ·Devalingam Mahalingam,Maccon Keane,Grisha Pirianov,Mehmet Haberal,Afshin Samali,Éva Szegezdi	2009	35
16	TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treatment Reviews ·Devalingam Mahalingam,Éva Szegezdi,Maccon Keane,Steven de Jong,Afshin Samali	2008	230
17	Decoy-insensitive TRAIL variants kill tumour cells more efficiently without damaging non-transformed cells Cancer Research ·Éva Szegezdi,Devalingam Mahalingam,Almer M. van der Sloot,Wim J. Quax,Maccon Keane,Afshin Samali	2007	1
18	Inhibition of NF-κB Activity Enhances TRAIL Mediated Apoptosis in Breast Cancer Cell Lines Breast Cancer Research and Treatment ·Maccon Keane,Yaffa Rubinstein,Mauricio Cuello,Seth A. Ettenberg,Priya R. Banerjee,Marion M. Nau,Stan Lipkowitz	2000	87
19	cbl-b inhibits epidermal growth factor receptor signaling Oncogene ·Seth A. Ettenberg,Maccon Keane,Marion M. Nau,Mark Frankel,Ling-Mei Wang,Jacalyn H. Pierce,Stan Lipkowitz	1999	103
20	Bcl-2 Rearrangement in Hodgkin’s Disease and Reactive Lymph Nodes American Journal of Clinical Pathology ·美枝奥村,Liam Grogan,Maccon Keane,D. Devaney,P. Dervan,Desmond N. Carney	1994	21

About Maccon Keane

Maccon Keane is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 72 papers that have together received 3.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (10 papers), Cell death mechanisms and regulation (9 papers), HER2/EGFR in Cancer Research (8 papers), Advanced Breast Cancer Therapies (8 papers), NF-κB Signaling Pathways (7 papers), Breast Lesions and Carcinomas (6 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Cancer Research (926 citations), Oncology (1.5k citations) and Immunology (630 citations). Maccon Keane has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Seth A. Ettenberg, Marion M. Nau, Stan Lipkowitz, E K Russell, Stanley Lipkowitz, Mauricio Cuello, Devalingam Mahalingam, Afshin Samali, Éva Szegezdi and Steven de Jong. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, European Journal of Cancer and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact